baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Epigenomics AG/ DE000A37FT41 /

2023-11-29 3:30:03 PM	Chg. -	Volume	Bid-	Ask-	High	Low
0.5000USD	-	250 Turnover: 125	-Bid Size: -	-Ask Size: -	0.5000	0.5000

GlobeNewswire 05-29 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...

GlobeNewswire 03-18 TLI Investigator Dr. Wei Yan Named Editor-in-Chief of the Andrology Journal

GlobeNewswire 02-15 Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselv...

GlobeNewswire 02-13 Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselv...

GlobeNewswire 2023-11-06 Novogene Asia Pacific Middle East and Africa adopts Olink® Explore HT technology to accelerate multi...

GlobeNewswire 2023-10-02 Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD

GlobeNewswire 2023-10-02 AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine

GlobeNewswire 2023-09-12 Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision m...

GlobeNewswire 2023-08-15 Lundquist Principal Investigator Dr. Michael Yeaman Awarded $11.5 Million NIAID/HHS Grant for Innova...

GlobeNewswire 2022-03-16 Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update

GlobeNewswire 2022-02-28 Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022

GlobeNewswire 2022-02-16 Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week o...

GlobeNewswire 2022-01-25 Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional...

GlobeNewswire 2022-01-11 Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Wee...

GlobeNewswire 2022-01-05 Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’2...

GlobeNewswire 2022-01-03 Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference

GlobeNewswire 2021-12-20 Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab

GlobeNewswire 2021-12-02 Progenity Announces New Patent for Single-Molecule Detection Technology

GlobeNewswire 2021-11-23 Progenity Strengthens its Liquidity Position

GlobeNewswire 2021-11-15 Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire 2021-11-11 OpGen Reports Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 2021-11-10 Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results

GlobeNewswire 2021-11-09 Progenity Appoints Adi Mohanty as Chief Executive Officer

GlobeNewswire 2021-11-04 OpGen Appoints Albert Weber as Chief Financial Officer

GlobeNewswire 2021-11-04 Progenity Announces Appointment of Jill Howe to its Board of Directors

Epigenomics AG/ DE000A37FT41 /

If you wish to receive reply to your feedback, please provide your email address.